Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

NCT00828555 | Completed

• 1 other identifier: Pro00011038
• Study Type: observational
• Target: 3,988
• Locations: 1 country
• Sites: 4

Brief Summary

PURPOSE To develop, implement, and evaluate the effectiveness of a program designed to assist community Ob/Gyns in vaccinating adolescent and adult women against vaccine-preventable diseases. SPECIFIC AIMS

• Attitudes towards vaccination of women against preventable diseases
• Perceived barriers to implementing a program to vaccinate women in their offices
• Ideas on how to overcome barriers to successful program implementation
• Current vaccination practices and office-specific administrative processes
• Design \& implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, \& pertussis
• Determine the effectiveness of the vaccination program based on
• Pre- and post-program vaccination rates
• Program satisfaction amongst Ob/Gyn providers and office staff
• Willingness to continue and possibly extend the program to additional vaccines
• Quantify the level of support and resources needed to develop and implement the vaccination program

Conditions

Influenza Vaccine; Papillomavirus Infection; Pertussis

Keywords

HPV vaccine; Tdap vaccine

Outcome Measures

Primary Outcomes (1)

• Implementation and measurement of a health services intervention in community or private Ob/Gyn practices to improve the delivery of standard clinical care to vaccinate women against human papillomavirus, influenza, & pertussis.

  Full-scale program implementation will cover a 12 month period, tentatively planned to begin in April 2009.

Interventions

Vaccination Program OTHER

Design \& implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, \& pertussis

Eligibility Criteria

• Age: 12 Years - 26 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

Population Groups: Adults Minors Patients Pregnant Women Fetuses

You may qualify if:

• community Ob/Gyn practices

Sponsors & Collaborators

• Duke University: lead
• Centers for Disease Control and Prevention: collaborator

Study Sites (4)

Westside OBGYN

Burlington, North Carolina, United States

Location

DWHA

Durham, North Carolina, 27707, United States

Location

Atrium OBGYN

Raleigh, North Carolina, United States

Location

Blue Ridge OBGYN

Raleigh, North Carolina, United States

Location

MeSH Terms

Conditions

Influenza, Human; Papillomavirus Infections; Whooping Cough

Condition Hierarchy (Ancestors)

Respiratory Tract Infections; Infections; Orthomyxoviridae Infections; RNA Virus Infections; Virus Diseases; Respiratory Tract Diseases; Sexually Transmitted Diseases, Viral; Sexually Transmitted Diseases; Communicable Diseases; DNA Virus Infections; Tumor Virus Infections; Genital Diseases; Urogenital Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Bordetella Infections; Gram-Negative Bacterial Infections; Bacterial Infections; Bacterial Infections and Mycoses

Study Officials

• Geeta Swamy, MD

  Duke University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 22, 2009
• First Posted: January 26, 2009
• Study Start: November 1, 2008
• Primary Completion: April 1, 2009
• Study Completion: February 1, 2012
• Last Updated: October 16, 2012

Record last verified: 2012-09

Locations

US (4)